| Patents for C07J 53 - Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by condensation with carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms (1,809) |
|---|
| 12/17/2003 | CN1461751A Cyclo virobuxine D preparation and its dispersoid preparation |
| 11/19/2003 | CN1456568A Organic salts of parabuxinidine-D, their preparations and uses |
| 11/13/2003 | WO2003092578A2 Further syntheses of cyproterone acetate |
| 11/13/2003 | CA2482997A1 Further syntheses of cyproterone acetate |
| 11/05/2003 | EP1359154A1 Further syntheses of cyproterone acetate |
| 10/22/2003 | CN1450900A Antitumor agents |
| 10/16/2003 | US20030195182 Triterpene derivatives and remedies for liver diseases |
| 10/09/2003 | US20030191102 Contraception method using competitive progesterone antagonists and novel compounds useful therein |
| 10/07/2003 | US6630587 Processes for preparation of 9,11-epoxy steroids and intermediates useful therein |
| 10/02/2003 | WO2003080778A2 Methods for treating deodorizer distillate |
| 10/02/2003 | CA2479773A1 Methods for treating deodorizer distillate |
| 09/25/2003 | US20030181429 Topically applying betulinic acid or a betulinic acid derivative to tumor site |
| 09/17/2003 | EP1343806A1 Methylene steroids as novel androgens |
| 09/17/2003 | EP1343483A2 Transdermal system containing a novel high potency progestagen |
| 09/03/2003 | EP0775156B1 Pharmaceutical compositions containing estra-1,3,5(10)-triene derivatives |
| 09/03/2003 | EP0767798B1 Sterol derivatives used for regulation of meiosis |
| 08/27/2003 | CN1438236A Method for purifying Huanweihuangyangxing D and preparation thereof |
| 08/26/2003 | US6610844 Removing an 11-alpha-leaving group from an epoxymexrenone derivative |
| 08/19/2003 | US6608074 Administering during follicular phase of female menstrual cycle and in luteal phase, a competitive progesterone antagonist, which is less than an ovulation-inhibiting dose and less than an abortion-inductive dose |
| 08/14/2003 | WO2003066659A2 Improved method for obtaining betulinic acid |
| 08/14/2003 | WO2003066656A1 Crystalline complexes of fluticasone 2-furoate |
| 08/14/2003 | WO2003066036A1 Pharmaceutical formulation for administration by inhalation comprising an androstane derivative and a beta-2-adrenoreceptor for the treatment of inflammatory and allergic conditions |
| 08/14/2003 | WO2003066032A1 Formulations for inhalation |
| 08/14/2003 | WO2003066026A1 Pharmaceutical formulation comprising an androstane derivative and a solubilising agent in an aqueous liquid carrier |
| 08/14/2003 | WO2003066024A1 Pharmaceutical formulation comprising an aqueous suspension of an androstane derivative for the treatment of inflammatory and allergic conditions |
| 08/14/2003 | US20030153542 Novel anti-inflammatory androstane derivative compositions |
| 08/14/2003 | US20030153538 Comprises as effective component a compound selected from maslinic acid, erythrodiol, uvaol, betulinic acid, betulin and physiologically acceptable salts thereof or derivatives thereof |
| 08/07/2003 | US20030149286 Process for obtaining betulinic acid |
| 07/31/2003 | WO2003062260A1 Triterpene quaternary salts as biologically active surfactants |
| 07/31/2003 | CA2473799A1 Triterpene quaternary salts as biologically active surfactants |
| 07/30/2003 | CN1433426A 16,17-carbocyclic condensed steroid compounds having seletive estrogenic activeity |
| 07/30/2003 | CN1433425A Unsaturated 14,15-cyclopropane-cendrostanes, a method for their production and pharmaceutical compositions containing these compounds |
| 07/24/2003 | US20030139385 Method of treating disorder related to high cholesterol concentration |
| 07/22/2003 | US6596713 Antigestagenic, antiglucocorticoidal, antimineralcorticoidal or antiandrogenic effect |
| 07/17/2003 | US20030134834 Antigestagenically active steroids with a fluorinated 17-alpha-alkyl chain |
| 07/15/2003 | US6593364 Oxireno-, azetidino-, and methano- picene derivatives |
| 07/10/2003 | US20030130246 Bile-acid derived compounds for enhancing oral absorption and systemic bioavailability of drugs |
| 07/10/2003 | US20030127621 Kinesin motor modulators derived from the marine sponge adocia |
| 07/03/2003 | WO2003053993A1 Androgenic 14.alpha, 17.alpha-ethenosteroids |
| 07/03/2003 | WO2002094849A3 Process for the production of 6, 7 - dihydroxy steroid compounds by allylic oxidation of steroid - 5 - ene compounds to steroid - 5 - ene - 7 - one compounds followed by hydroboration and oxidation and intermediates of this process |
| 07/01/2003 | US6586591 Process for preparation of 9,11-epoxy steroids and intermediates useful therein |
| 06/26/2003 | US20030119715 Prevent retinoid binding; antiaging agents; activation cell differentiation |
| 06/25/2003 | EP1321145A1 Antitumor agents |
| 06/24/2003 | US6583131 Cationic cholesteryl derivatives containing cyclic polar groups |
| 06/18/2003 | EP1318836A2 Treatment of hyperproliferative diseases |
| 06/11/2003 | EP0981341B1 Use of betulinic acid derivatives for the treatment and prevention of melanoma |
| 05/29/2003 | US20030100543 Novel steroids containing a 14 beta ,15 beta - cyclopropane ring and a 17 alpha hydroxymethyl group; male contraceptives |
| 05/29/2003 | US20030100541 Processes for preparation of 9,11-epoxy steroids and intermediates useful therein |
| 05/28/2003 | EP1313485A2 Use of an aldosterone receptor antagonist to improve cognitive function |
| 05/28/2003 | CN1109689C 14 alpha, 17 alpha-C2-bridged 19-nor-progesterone derivatives |
| 05/27/2003 | US6569844 Pharmaceutical preparations containing estra-1,3,5(10)-triene derivatives |
| 05/14/2003 | EP0830369B1 Nor-pregnanes for inducing hypothalamic effects |
| 05/14/2003 | CN1108307C New saponin compound and its preparation method and application |
| 05/08/2003 | US20030085379 Contrast; for use in spatial light modulator, and liquid crystal display of optically-addressed or thermally-addressed type |
| 05/02/2003 | EP0811006B1 Benzopyran-containing compounds and method for their use |
| 04/30/2003 | CN1413588A Drug composition containing Fructus Tribuli fruit total saponin and its preparation method |
| 04/23/2003 | EP1242445B1 14,15-cyclopropanosteroids of the 19-norandrostane series, method for producing said compounds and pharmaceutical preparation containing said compounds |
| 04/17/2003 | US20030073858 Methods for manufacturing betulinic acid |
| 04/17/2003 | US20030073676 Dissolving in aqueous carrier; antiallergens |
| 04/10/2003 | WO2003020214A3 Bile-acid derived compounds for enhancing oral absorption and systemic bioavailability of drugs |
| 03/27/2003 | US20030060646 Process for preparing17alpha-acetoxy-11beta-[4-n,n(dimethylamino)phenyl]-21-methoxy-19-norpregna-4,9-diene -3,20-dione, intermediates useful in the process , and processes for preparing such intermediates |
| 03/26/2003 | EP1294739A1 16,17-carbocyclic condensed steroid compounds having selective estrogenic activity |
| 03/20/2003 | US20030055274 Processes for preparation of 9,11-epoxy steroids and intermediates useful therein |
| 03/19/2003 | CN1403470A Astragalus saponin A with the function of resisting myocardial fibrillation |
| 03/18/2003 | US6534490 Unsaturated 14, 15-cyclopropanoandrostanes, method for the production thereof and pharmaceutical preparations containing said compounds |
| 03/13/2003 | WO2003020214A2 Bile-acid derived compounds for enhancing oral absorption and systemic bioavailability of drugs |
| 03/13/2003 | US20030050286 Steroids with a cyclohexene moiety are oxidized to the corresponding alpha, beta-unsaturated ketone that is converted to the corresponding vicinal diol using a hydroborating reagent followed by oxidative workup |
| 03/12/2003 | CN1402735A Novel androgens |
| 02/20/2003 | US20030036540 Betulinol derivatives |
| 02/19/2003 | EP1284273A2 Estra-1,3,5(10)-trien-3-sulfamates a process for their production and pharmaceutical compositions containing them |
| 02/06/2003 | WO2002017895A3 Use of an aldosterone receptor antagonist to improve cognitive function |
| 02/05/2003 | EP0988311A4 Betulinol derivatives |
| 01/30/2003 | WO2002009719A1 Antitumor agents |
| 01/30/2003 | CA2418117A1 Antitumor agent |
| 01/29/2003 | CN1100062C Medicine for curing presenile dementia and cerebral apoplexy sequelae |
| 01/23/2003 | WO2001005805A9 Novel c-19-halogen-substituted, 5-substituted, 5-substituted or 6,10 carbocyclically condensed steroids of the androst-9(11)-ene-series, methods for the production and use thereof |
| 01/09/2003 | WO2002049622A3 Transdermal system containing a novel high potency progestagen |
| 01/08/2003 | EP1273590A2 Estra- 1,3,5(10)-triene Derivatives, Methods of Preparing Such Compounds and Pharmaceutical Compositions Containing Them |
| 01/07/2003 | US6503895 Antigestagenically active steroids with a fluorinated 17α-alkyl chain |
| 01/02/2003 | US20030004148 Regulation of meiosis |
| 01/02/2003 | US20030003139 Transdermal system that contains a new highly potent gestagen |
| 12/18/2002 | EP1266658A2 Use of betulinic acid derivatives for the treatment and prevention of melanoma |
| 12/17/2002 | US6495600 Method and composition for selectively inhibiting melanoma |
| 12/05/2002 | US20020183283 Meiosis regulating compounds |
| 12/03/2002 | US6489134 Kinesin motor modulators derived from the marine sponge Adocia |
| 11/28/2002 | WO2002094849A2 Process for the production of 6, 7 - dihydroxy steroid compounds by allylic oxidation of steroid - 5 - ene compounds to steroid - 5 - ene - 7 - one compounds followed by hydroboration and oxidation and intermediates of this process |
| 11/28/2002 | US20020177581 Novel anti-inflammatory androstane derivative |
| 11/28/2002 | CA2447780A1 Process for the production of 6, 7 - dihydroxy steroid compounds by allylic oxidation of steroid - 5 - ene compounds to steroid - 5 - ene - 7 - one compounds followed by hydroboration and oxidation and intermediates of this process |
| 11/21/2002 | WO2002092618A1 17 alpha-hydroxy-4-androstene-3-one and the 14, 15-methylene-derivatives thereof |
| 11/21/2002 | US20020173496 Formulation containing novel anti-inflammatory androstane derivative |
| 11/20/2002 | EP1163259B1 14.beta.,17-alpha-hydroxymethylandrostane derivatives as androgens |
| 11/13/2002 | CN1379040A Soluble inorganic salt of Huanweihuangyangxing D, its preparing process and medicine containing it |
| 11/07/2002 | US20020165211 Aqueous suspension of Fluticasone furoate; respiratory tract disorders; asthma, COPD; antiinflammatory, antiallergen; nasal inhaler |
| 11/06/2002 | EP0639970B2 Contraception method using competitive progesterone antagonists and novel compounds useful therein |
| 11/05/2002 | US6475520 Pharmaceutical composition with low toxicity for anti-inflammation and anti-exudation |
| 10/17/2002 | WO2002015920A3 Treatment of hyperproliferative diseases |
| 10/02/2002 | EP0944644B1 PROCESSES FOR PREPARATION OF 3-KETO-7alpha-ALKOXYCARBONYL-delta-4,5- STEROIDS AND INTERMEDIATES USEFUL THEREIN |
| 09/25/2002 | EP1242445A1 14,15-cyclopropanosteroids of the 19-norandrostane series, method for producing said compounds and pharmaceutical preparation containing said compounds |
| 09/25/2002 | EP1242444A1 Process for preparing 17alpha-acetoxy-11beta- 4-n,n-(dimethylamino)phenyl]-21-methoxy-19-norpregna-4,9-diene-3,20-dione, intermediates useful in the process, and processes for preparing such intermediates |
| 09/12/2002 | US20020128242 Novel cationic cholesteryl derivatives containing cyclic polar groups |